| Literature DB >> 23743494 |
Rami Khayat1, Roy Small, Lisa Rathman, Steven Krueger, Becky Gocke, Linda Clark, Laura Yamokoski, William T Abraham.
Abstract
Sleep-disordered breathing (SDB) is the most common comorbidity in patients with heart failure (HF) and has a significant impact on quality of life, morbidity, and mortality. A number of therapeutic options have become available in recent years that can improve quality of life and potentially the outcomes of HF patients with SDB. Unfortunately, SDB is not part of the routine evaluation and management of HF, so it remains untreated in most HF patients. Although recognition of the role of SDB in HF is increasing, clinical guidelines for the management of SDB in HF patients continue to be absent. This article provides an overview of SDB in HF and proposes a clinical care pathway to help clinicians to better recognize and treat SDB in their HF patients.Entities:
Mesh:
Substances:
Year: 2013 PMID: 23743494 PMCID: PMC3690313 DOI: 10.1016/j.cardfail.2013.04.005
Source DB: PubMed Journal: J Card Fail ISSN: 1071-9164 Impact factor: 5.712